Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development Formulation

Benign by Design

A wide range of chemicals end up in our water systems, threatening both the environment and our drinking water. And pharmaceuticals are certainly on the hit list. Strategies to prevent APIs entering our water supplies can be expensive but they are not always effective. To that end, Klaus Kümmerer and his team at Leuphana University in Germany are attempting to give medicines a green makeover by redesigning existing pharmaceuticals to be biodegradable (1). Here, Kümmerer tells us more about his ‘benign-by-design’ strategy.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register